You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drugs Containing Excipient (Inactive Ingredient) AMMONIA


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing AMMONIA excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
Genentech Inc CELLCEPT mycophenolate mofetil 0004-0260 AMMONIA
Pfizer Laboratories Div Pfizer Inc IBRANCE palbociclib 0069-0187 AMMONIA
Eli Lilly and Company RETEVMO selpercatinib 0002-3977 AMMONIA 2038-10-10
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 AMMONIA
Haleon US Holdings LLC VOLTAREN diclofenac sodium 0067-8152 AMMONIA
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 5 of 5 entries

Generic drugs containing AMMONIA excipient

The Market Dynamics and Financial Trajectory of Ammonium Acetate in the Pharmaceutical Industry

Introduction

Ammonium acetate, a crucial pharmaceutical excipient, is experiencing significant growth driven by various factors in the pharmaceutical, food, and agricultural sectors. Here, we delve into the market dynamics and financial trajectory of ammonium acetate, highlighting its role, growth prospects, and challenges.

Role of Ammonium Acetate in Pharmaceuticals

Buffer Solutions and Excipients

Ammonium acetate is extensively used in pharmaceutical applications, particularly as a buffer solution and excipient. It enhances the solubility, bioavailability, and stability of active pharmaceutical ingredients (APIs), making it indispensable in modern drug development[1][2].

Synthesis of Active Pharmaceutical Ingredients (APIs)

The compound plays a vital role in the synthesis of APIs, contributing to the growth of the global API market, which is expected to reach USD 314.9 billion by 2026, growing at a CAGR of 6.7% from 2021 to 2026[1].

Market Size and Growth Prospects

Current Market Size

The global ammonium acetate market was valued at USD 9.29 billion in 2023 and is estimated to reach USD 9.64 billion in 2024. It is projected to grow to USD 12.99 billion by 2032, with a CAGR of 3.8% during the forecast period (2024-2032)[1].

Pharmaceutical Excipients Market

The broader pharmaceutical excipients market, within which ammonium acetate operates, was valued at USD 8.39 billion in 2023 and is expected to grow to USD 14.80 billion by 2033, at a CAGR of 5.84% from 2024 to 2033[3].

Key Drivers of Growth

Increasing Demand in Pharmaceuticals

The growing demand for innovative drug formulations, especially for chronic diseases such as diabetes, hypertension, cancer, and HIV, drives the need for effective excipients like ammonium acetate. The pharmaceutical industry's rapid growth and substantial investments in research and development (totaling USD 183 billion in 2021) further boost demand[1][2].

Food and Beverage Industry

The use of ammonium acetate as a food additive, acidity regulator, and preservative in the food and beverage industry also contributes significantly to market growth[1].

Agricultural Sector

Ammonium acetate's role in chemical synthesis, catalysis, and as an ingredient in agricultural pesticides and fertilizers adds to its market demand. The Asia Pacific region, particularly China and India, shows robust growth driven by increasing agricultural demand[1].

Regional Market Dynamics

Asia Pacific

The Asia Pacific region is the most significant global market shareholder for ammonium acetate. China stands out as a key producer and consumer, with a domestic production capacity of around 600,000 tons in 2020. India also shows significant growth potential, fueled by rising demand from the agrochemical and pharmaceutical sectors[1].

North America and Europe

North America and Europe also hold substantial market shares, with North America accounting for 39% of the pharmaceutical excipients market in 2023, and Europe holding 30%[3].

Challenges and Regulatory Environment

Stringent Regulatory Standards

The pharmaceutical excipients market, including ammonium acetate, faces a stringent regulatory environment. Compliance with these regulations requires significant investment in research and testing, which can be a barrier to entry for smaller market players[2].

Geopolitical and Economic Factors

Geopolitical instability, climate disruption, raw material shortages, economic uncertainty, and manufacturing bottlenecks can disrupt the market. However, the industry's focus on innovation and strategic collaborations helps mitigate these challenges[2].

Future Outlook and Innovations

Personalized Medicine and Precision Therapeutics

The growing emphasis on personalized medicine and precision therapeutics will drive demand for tailored excipient solutions, supporting individualized drug formulations. This trend is expected to continue driving innovation in the pharmaceutical excipients market[2].

Biopharmaceuticals

The rise of biopharmaceuticals and the increased need for reliable buffer solutions underscore the crucial role of ammonium acetate in meeting stringent regulatory standards. This ensures continued growth prospects for the compound in the pharmaceutical sector[1].

Key Takeaways

  • Market Growth: The global ammonium acetate market is projected to grow from USD 9.29 billion in 2023 to USD 12.99 billion by 2032, at a CAGR of 3.8%.
  • Pharmaceutical Applications: Ammonium acetate is vital in pharmaceutical applications, including buffer solutions, excipients, and API synthesis.
  • Regional Dynamics: The Asia Pacific region, particularly China and India, drives significant market growth.
  • Challenges: The market faces stringent regulatory standards, geopolitical instability, and economic uncertainties.
  • Future Outlook: The trend towards personalized medicine and the rise of biopharmaceuticals will continue to drive demand for ammonium acetate.

FAQs

What is the current market size of the global ammonium acetate market?

The global ammonium acetate market was valued at USD 9.29 billion in 2023[1].

What is the projected growth rate of the global ammonium acetate market?

The market is expected to grow at a CAGR of 3.8% from 2024 to 2032[1].

Which region is the most significant market shareholder for ammonium acetate?

The Asia Pacific region is the most significant global market shareholder for ammonium acetate[1].

What are the key drivers of growth for the ammonium acetate market?

Key drivers include increasing demand in pharmaceuticals, the food and beverage industry, and the agricultural sector[1].

What challenges does the ammonium acetate market face?

The market faces challenges such as stringent regulatory standards, geopolitical instability, and economic uncertainties[2].

How does the trend towards personalized medicine impact the demand for ammonium acetate?

The growing emphasis on personalized medicine and precision therapeutics will drive demand for tailored excipient solutions, including ammonium acetate[2].

Sources

  1. Straits Research: Ammonium Acetate Market Size, Demand & Analysis Report by 2032.
  2. BCC Research: Understanding the Future of Pharmaceutical Excipients.
  3. Vision Research Reports: Pharmaceutical Excipients Market Size to Surge to US$ 14.72 Billion by 2033.
  4. Mordor Intelligence: Ammonia Market Report | Industry Analysis, Size & Growth Outlook.
  5. Wiley: Pharmaceutical Manufacturing Handbook - Production and Processes.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.